Incyte Corp

NASDAQ: INCY
$60.73
+$0.03 (+0.0%)
Closing Price on July 10, 2024

INCY Chart and Intraday Price

INCY Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TRADE & SERVICES
Industry SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Address 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 13,258.26M USD
Shares Outstanding 224,526,000
Incyte Corp is a biopharmaceutical company focused on developing and commercializing treatments for cancer and autoimmune diseases. It is known for its flagship product, JAKAFI, used in treating various blood-related disorders, and has a diverse portfolio including therapies for leukemia, lymphoma, and skin diseases. Incyte is actively involved in research, with several products in clinical trials aiming to address unmet medical needs in oncology and inflammation. The company collaborates with other pharmaceutical entities to expand its reach and improve patient care globally. Headquartered in Wilmington, Delaware, Incyte continues to innovate in the healthcare space.

INCY Articles

Friday's top analyst upgrades and downgrades included Builders FirstSource, CVS Health, DHT, Incyte, McDonald's, Newell Brands, PacWest Bancorp, Wingstop and ZoomInfo Technologies.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Amcor, Caesars Entertainment, CarMax, Chewy, Marriott International, Microsoft, Molson Coors Beverage, NXP...
Tuesday's top analyst upgrades and downgrades included American Homes 4 Rent, Block, Catalent, Cushman & Wakefield, Hasbro, McDonald's, NetApp, Pioneer Natural Resources, Regions Financial,...
Tuesday's top analyst upgrades and downgrades included Alphabet, Caterpillar, Corning, Digital Realty Trust, Dish Network, KeyCorp, Nvidia, Pinterest, Roku, Tesla and Wynn Resorts.
Monday's top analyst upgrades and downgrades included Altria, Block, Coinbase Global, Deere, First Horizon, KB Home, Pfizer, PNC Financial Services, RingCentral, Uber Technologies znd Zoom Video...
Tuesday's top analyst upgrades and downgrades included Amgen, Caterpillar, CF Industries, Coinbase Global, Fastly, Match, Newmont, Okta, Progressive, Toast, Under Armour, Walt Disney and Zim...
More AI-enabled search chatbots to compete with Google, and Manchester United may have found a buyer.
Wednesday's top analyst upgrades and downgrades included Alphabet, Bank of America, Dollar General, Edwards Lifesciences, Fortinet, Fox, Halliburton, LyondellBasell Industries, Paramount Global, SoFi...
Thursday's top analyst upgrades and downgrades included BioCryst Pharmaceutical, Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton Interactive, Snowflake, SoFi...
Wednesday's top analyst upgrades and downgrades included Coterra Energy, EOG Resources, FedEx, Fortinet, Hertz Global, Palo Alto Networks, Range Resources, Stem, TechnipFMC, Twilio and United Parcel...
Wednesday's additional top analyst upgrades and downgrades included CF Industries, Cognex, Incyte, PayPal, XPeng and Xylem.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Airbnb, Block, Caesars Entertainment, CarMax, Lyft, Nike, Paramount Global, S&P Global and Starbucks.
Here is another look at Exelon, Incyte and other stocks that Wall Street analysts expected little from in this past week.
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Enphase Energy, General Motors, Incyte, Lyft, MP Materials, Newmont, Tenet Healthcare and Vale.
Here is a look at five stocks that traded up and five that traded lower in Tuesday's premarket session.